LambdaVision Incorporated
Founded 2018 · 13 employees on LinkedIn · 6 known investors
Find your way into LambdaVision Incorporated
Sign up to see every warm intro you have to LambdaVision Incorporated
- Paths you didn't know you had: your email and LinkedIn already hold routes to the LambdaVision Incorporated team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LambdaVision develops a protein-based artificial retina designed to restore vision for patients blinded by advanced retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The implant uses proteins similar to the visual pigment rhodopsin to mimic the light-absorbing function of damaged photoreceptor cells, and its manufacturing leverages space-based production.
Founders & leadership
LambdaVision Incorporated was founded in 2018 by Robert R. Birge.


Investors · 6
How we know: the company's own site · Aurelia Foundry's portfolio page · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · a partner's Signal profile · sevensevensix.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: E2MC Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Related companies · 1
Companies working in the same space as LambdaVision Incorporated.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| NASA | Phase I | 2023 | $156.5K |
| NASA | Phase I | 2023 | $150K |
| NASA | Phase II | 2020 | $749.5K |
| NASA | Phase I | 2019 | $121.6K |
| National Science Foundation | Phase II | 2016 | $742.2K |
| National Science Foundation | Phase I | 2015 | $149.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $190.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does LambdaVision Incorporated do?
- LambdaVision develops a protein-based artificial retina designed to restore vision for patients blinded by advanced retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The implant uses proteins similar to the visual pigment rhodopsin to mimic the light-absorbing function of damaged photoreceptor cells, and its manufacturing leverages space-based production.
- Who founded LambdaVision Incorporated?
- LambdaVision Incorporated was founded by Robert R. Birge in 2018.
- Who are LambdaVision Incorporated's investors?
- LambdaVision Incorporated's investors include Aurelia Foundry, Connecticut Innovations, Seraphim Space, Seven Seven Six, Band of Angels, E2MC Ventures.


